Trial Outcomes & Findings for Stereotactic Radiation to Decrease Pancreatic Secretions (NCT NCT01656486)
NCT ID: NCT01656486
Last Updated: 2022-06-10
Results Overview
Measurement of pancreatic panel, decreased Pancreatic Secretions
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
1 participants
Primary outcome timeframe
1 year
Results posted on
2022-06-10
Participant Flow
Participant milestones
| Measure |
Stereotactic Radiation
Treatment of pancreas with 30 Gy of radiation given in 5 fractions of 6 Gy each with stereotactic radiosurgery.
Stereotactic Radiation: Treatment of pancreas with 30 Gy of radiation given in 5 fractions of 6 Gy each with stereotactic radiosurgery that could produce a fibrosis of the pancreas and a decrease in the production of exocrine portion of the gland.
|
|---|---|
|
Overall Study
STARTED
|
1
|
|
Overall Study
COMPLETED
|
1
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Stereotactic Radiation to Decrease Pancreatic Secretions
Baseline characteristics by cohort
| Measure |
Stereotactic Radiation
n=1 Participants
Treatment of pancreas with 30 Gy of radiation given in 5 fractions of 6 Gy each with stereotactic radiosurgery.
Stereotactic Radiation: Treatment of pancreas with 30 Gy of radiation given in 5 fractions of 6 Gy each with stereotactic radiosurgery that could produce a fibrosis of the pancreas and a decrease in the production of exocrine portion of the gland.
|
|---|---|
|
Age, Continuous
|
43 years
STANDARD_DEVIATION 0 • n=5 Participants
|
|
Sex: Female, Male
Female
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
1 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 1 yearMeasurement of pancreatic panel, decreased Pancreatic Secretions
Outcome measures
| Measure |
Stereotactic Radiation
n=1 Participants
Treatment of pancreas with 30 Gy of radiation given in 5 fractions of 6 Gy each with stereotactic radiosurgery.
Stereotactic Radiation: Treatment of pancreas with 30 Gy of radiation given in 5 fractions of 6 Gy each with stereotactic radiosurgery that could produce a fibrosis of the pancreas and a decrease in the production of exocrine portion of the gland.
|
|---|---|
|
Decreased Secretions
|
1 participants
|
Adverse Events
Stereotactic Radiation
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place